摘要
目的对依达拉奉联合胞二磷胆碱治疗急性缺血性脑梗死患者的神经功能的影响研究。方法选取2015年6月至2016年6月在东港市中医院脑病二科就诊的60例急性缺血性脑梗死患者,随机分为试验组和对照组,对照组30例,采取常规治疗,对照组30例,采取依达拉奉联合胞二磷胆碱联合治疗,比较两组患者的神经功能缺损情况。结果试验组的神经功能缺损评分高于对照组,差异有统计学意义(P<0.05)。结论采用依达拉奉联合胞二磷胆碱治疗急性缺血性脑梗死患者可以明显降低患者的神经功能缺损情况,值得在临床推广。
Objective To in accordance with edaravone in combined therapy with cytidine diphosphate choline of neural function in patients with acute, ischemic cerebral infarction impact study. Methods Selection in June 2015 to June 2016 in donggang hospital encephalopathy two families of 60 patients with acute, ischemic cerebral infarction, were randomly divided into trial group and control group, 30 cases of control group treated with conventional, 30 cases of control group take the adr in joint combination treatment with cytidine diphosphate choline, comparing two groups of patients with neurologic deficits. Results The experimental group of nerve function defect score higher than the control group, the difference was statistically significant(P0.05). Conclusion The combined therapy with cytidine diphosphate choline in patients with acute, ischemic cerebral infarction can obviously reduce the patient's neurologic deficits, is worth popularizing in clinical.
出处
《中国医药指南》
2017年第31期60-61,共2页
Guide of China Medicine
关键词
依达拉奉
胞二磷胆碱
急性缺血性脑梗死
Pursuant to the adr
Cyfidine diphosphate choline
'Acute, ischemic cerebral infarction